Home
Finance

Work Area: Finance

IP-backed lending is becoming a serious option for many companies

Utilising patents as collateral for credit can save expense or even provide capital when VC or traditional lenders refuse

How the IVSC is preparing to accelerate intangible assets valuation in Asia

After establishing an office in Asia, the CEO of the International Valuation Standards Council expands on plans to escalate intangible assets valuation in the region

Lessons from China's $46 billion IP financing market

After over a decade and the involvement of various stakeholders, China achieved $46 billion in IP financing in 2021

Latest content

Future of former Yahoo! patents comes back on the agenda

No free passes insists Excalibur head as he contemplates future of $250m portfolio after parent company announces dissolution

05 April 2019

New research highlights impact of patent eligibility uncertainty on life sciences and tech investments

Academic calls for Congress to act on 101 “to restore investor confidence” with private equity and VC players clear that doubts over patentability make it less likely they will part with cash

14 March 2019

IP Bridge approaches milestone transition to private backing

The public-private INCJ is getting ready to exit in the IP business run by Shigeharu Yoshii (pictured, centre). The patent fund operator’s second act will tell us much about Japan’s IP market

08 March 2019

Lone inventor takes on Huawei in case that exposes the deep disparities in the US patent system

Portuguese national says he has sold his house to hire an attorney to go after the Chinese company over alleged IP theft – a huge leap of faith given US assertion realities

07 March 2019

The state of play in the global IP market

IAM's annual benchmarking survey is designed to identify the key concerns of senior decision makers in areas such as deal-making, valuation, patent office performance, top litigation venues and policy

06 March 2019

Burford takes aim at opioid overdose medication in series of IPRs

Reviews challenge validity of patents owned by Opiant Pharmaceuticals relating to Narcan brand of naloxone as price of treatments rises

21 February 2019

New Acacia chief IP officer charts a different course for the once mighty NPE

Supported by a healthy balance sheet, Marc Booth says the firm plans on a higher volume of smaller deals with three new areas identified for future growth

19 February 2019

Takeover wars intensify between listed IP firms in Australia

Aggressive move by the country’s largest public IP services group seems designed to thwart the merger of two smaller rivals. But further consolidation in the space still looks likely

15 February 2019

IPBC Global 2019 is shaping up to be the biggest and best of the series so far

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco

13 February 2019

New investment platform aims to break down barriers to capital for innovators

Former IV unit teams up with alternative asset business to give large and small innovators way of attracting finance on Blockchain-based initiative

12 February 2019

Get unlimited access to all IAM content